tiprankstipranks
Trending News
More News >
Shanghai Fosun Pharmaceutical (Group) Co Ltd Class H (SFOSF)
OTHER OTC:SFOSF

Shanghai Fosun Pharmaceutical (Group) Co (SFOSF) Revenue

Compare
26 Followers

Shanghai Fosun Pharmaceutical (Group) Co Revenue

Shanghai Fosun Pharmaceutical (Group) Co had a revenue of 10.09B in the quarter ending Jun 30, 2025, with 7.15%. This bring the company's revenue in the last twelve months to 40.12B, Increased -0.52%. In the fiscal year ending Dec 31, 2024, Shanghai Fosun Pharmaceutical (Group) Co had annual revenue of 41.07B with -0.80% growth.
Revenue (ttm)
40.12B
Revenue Growth
P/S Ratio
0.23
Revenue/Employee
$1,012,580
Employees
40,557
Market Cap
$9.29B

Revenue Chart

Revenue History
Fiscal End Date
Revenue
Change
Growth
Dec 31, 2024
41.07B-332.34M-0.80%
Dec 31, 2023
41.40B-2.55B-5.81%
Dec 31, 2022
43.95B4.95B+12.68%
Dec 31, 2021
39.01B8.70B+28.70%
Dec 31, 2020
30.31B1.72B+6.02%
Dec 31, 2019
28.59B3.67B+14.72%
Dec 31, 2018
24.92B6.38B+34.45%
Dec 31, 2017
18.53B